Eduardo Villacorta

ORCID: 0000-0003-0486-1740
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiomyopathy and Myosin Studies
  • Cardiovascular Function and Risk Factors
  • Cardiac Valve Diseases and Treatments
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Cardiovascular Effects of Exercise
  • Infective Endocarditis Diagnosis and Management
  • Congenital heart defects research
  • Parathyroid Disorders and Treatments
  • Cardiac Imaging and Diagnostics
  • Cardiac Arrhythmias and Treatments
  • Cardiac Structural Anomalies and Repair
  • Cardiac electrophysiology and arrhythmias
  • Viral Infections and Immunology Research
  • Cardiac pacing and defibrillation studies
  • Antimicrobial Resistance in Staphylococcus
  • Sarcoidosis and Beryllium Toxicity Research
  • Pericarditis and Cardiac Tamponade
  • Pulmonary Hypertension Research and Treatments
  • Streptococcal Infections and Treatments
  • Infectious Aortic and Vascular Conditions
  • Acute Myocardial Infarction Research
  • COVID-19 Clinical Research Studies
  • Family and Patient Care in Intensive Care Units
  • Aortic aneurysm repair treatments
  • Long-Term Effects of COVID-19

Instituto de Investigación Biomédica de Salamanca
2015-2025

Universidad de Salamanca
2005-2025

Complejo Hospitalario de Salamanca
2018-2025

Centro de Investigación en Red en Enfermedades Cardiovasculares
2018-2025

Centro de Investigación Biomédica en Red
2018-2025

Instituto de Salud Carlos III
2020-2024

Assistance Publique – Hôpitaux de Paris
2018-2024

Sorbonne Université
2024

Hospital Son Llatzer
2024

Health Research Institute of the Balearic Islands
2024

There is no agreement in the best cutoff time to distinguish between early- and late- onset prosthetic valve endocarditis (PVE). Our objectives are define early-onset PVE according microbiological spectrum analyse profile short-term prognosis of this entity.The 172 non-drug users, who were patients with PVE, compared elapsed from surgery among 640 diagnosed 1996 2004. differences occurred within 2 months replacement those accounting 12 months. The proportion coagulase-negative Staphylococci...

10.1093/eurheartj/ehl486 article EN European Heart Journal 2007-01-25

The Cardiomyopathy Registry of the EURObservational Research Programme is a prospective, observational, and multinational registry consecutive patients with four cardiomyopathy subtypes: hypertrophic (HCM), dilated (DCM), arrhythmogenic right ventricular (ARVC), restrictive (RCM). We report baseline characteristics management adults enrolled in registry. A total 3208 were by 69 centres 18 countries [HCM (n = 1739); DCM 1260); ARVC 143); RCM 66)]. Differences between subtypes (P < 0.001)...

10.1093/eurheartj/ehx819 article EN European Heart Journal 2018-01-09

Background: Truncating variants in the TTN gene (TTNtv) are commonest cause of heritable dilated cardiomyopathy. This study aimed to phenotypes and outcomes TTNtv carriers. Methods: Five hundred thirty-seven individuals (61% men; 317 probands) with were recruited 14 centers (372 [69%] baseline left ventricular systolic dysfunction [LVSD]). Baseline longitudinal clinical data obtained. The primary end point was a composite malignant arrhythmia end-stage heart failure. secondary reverse...

10.1161/circheartfailure.119.006832 article EN Circulation Heart Failure 2020-09-23

Abstract Aims The aim of this study was to determine the frequency heterozygous truncating ALPK3 variants (ALPK3tv) in patients with hypertrophic cardiomyopathy (HCM) and confirm their pathogenicity using burden testing independent cohorts family co-segregation studies. Methods results In a discovery cohort 770 index HCM, 12 (1.56%) were for ALPK3tv [odds ratio(OR) 16.11, 95% confidence interval (CI) 7.94–30.02, P = 8.05e−11] compared Genome Aggregation Database (gnomAD) population....

10.1093/eurheartj/ehab424 article EN cc-by European Heart Journal 2021-06-18
Fernando de Frutos Juan Pablo Ochoa Marina Navarro Peñalver Annette F. Baas Jesper Vandborg Bjerre and 95 more Esther Zorio Irene Méndez Rebeca Lorca Job A.J. Verdonschot Pablo Elpidio García-Granja Zofia T. Bilińska Diane Fatkin María Eugenia Fuentes‐Cañamero José Manuel García‐Pinilla Ana García‐Álvarez Francesca Girolami Roberto Barriales‐Villa Carles Díez‐López Luís R. Lopes Karim Wahbi Ana García‐Álvarez Ibon Rodríguez-Sánchez Javier Rekondo-Olaetxea José F. Rodríguez‐Palomares María Gallego‐Delgado Benjamin Meder Miloš Kubánek Frederikke G. Hansen Maria Alejandra Restrepo‐Córdoba Julián Palomino-Doza Luis Ruiz‐Guerrero Geòrgia Sarquella-Brugada Alberto José Perez-Perez Francisco Bermúdez-Jiménez Tomás Ripoll‐Vera Torsten B. Rasmussen M. Jansen María Sabater‐Molina Perry M Elliot Pablo García‐Pavía Eva Cabrera-Romero Marta Cobo Marcos Luis Escobar-López Fernándo Domínguez Esther González-López Juan R. Gimeno Dennis Dooijes Bernabé López Ledesma Inés Roche Fortea Javier Bermejo María Ángeles Espinosa Ana I. Fernández Silvia Vilches Cristina Mateo Gómez Juan Gómez Eliécer Coto J.J.R. Reguero Stéphane Heymans Han G. Brunner Javier López Grażyna Truszkowska Rafał Płoski Przemysław Chmielewski Renée Johnson Ainhoa Robles Mezcua Arancha Díaz-Expósito Alejandro Pérez Cabeza Clara Jiménez-Rubio Vicente Climent Silvia Favilli Petros Syrris Douglas Cannie Clarisse Billon Ángela López‐Sainz Margarita Calvo Ángela Cacicedo Fernández de Bobadilla Jose Juan Onaindia-Gandarias Larraitz Gaztañaga-Arantzamendi Estibaliz Zamarreño-Golvano Javier Limeres Freire Laura Gutiérrez-García Eduardo Villacorta Jan Haas Alice Krebsová Jens Mogensen Sergi César Óscar Campuzano Raúl Franco‐Gutiérrez Jorge Álvarez-Rubio David Cremer-Luengos Guido Antoniutti Fiama Caimi-Martínez Rosa Macías Juan Jiménez‐Jáimez María Luisa Peña‐Peña Salvador Lucas Díez-Aja López Tania Pino Acereda Blanca Arnáez Corada Jesús Piqueras‐Flores Martín Negreira Caamaño

Variants in myosin heavy chain 7 (MYH7) are responsible for disease 1% to 5% of patients with dilated cardiomyopathy (DCM); however, the clinical characteristics and natural history MYH7-related DCM poorly described.We sought determine phenotype prognosis DCM. We also evaluated influence variant location on phenotypic expression.We studied data from 147 individuals DCM-causing MYH7 variants (47.6% female; 35.6 ± 19.2 years) recruited 29 international centers.At initial evaluation, 106...

10.1016/j.jacc.2022.07.023 article EN cc-by-nc-nd Journal of the American College of Cardiology 2022-08-22

Fabry disease (FD) is a X-linked rare lysosomal storage disorder caused by deficient α-galactosidase A (α-GalA) activity. Early diagnosis and the prediction of course are complicated clinical heterogeneity FD, as well frequently inconclusive biochemical genetic test results that do not correlate with course. We sought to identify potential biomarkers FD better understand underlying pathophysiology phenotypes. compared plasma proteomes 50 patients matched healthy controls using DDA SWATH-MS....

10.1016/j.trsl.2024.02.006 article EN cc-by-nc Translational research 2024-02-21

Aims Surgery in patients with infective endocarditis (IE) can be elective (upon completion of antibiotic treatment) or urgent (before treatment has ended) when the clinical course is unfavourable. However, surgery for left-sided associated high mortality. The aims this study were to describe profile who underwent and analyse factors that predicted Methods results Among 508 consecutive episodes IE, 391 89 required surgery. main reasons heart failure did not respond medication (72%) persistent...

10.1093/eurheartj/ehl315 article EN European Heart Journal 2006-06-13

The influence of age on the main epidemiological, clinical, echocardiographic, microbiological, and prognostic features patients with infective endocarditis remains unknown. We present series largest numbers range ages subjects to date that analyzes characteristics isolated left-sided endocarditis. Furthermore, this is first one in which have been distributed according quartile.A total 600 episodes consecutively diagnosed 3 tertiary centers were stratified into age-specific quartiles 107...

10.1161/circulationaha.109.877365 article EN Circulation 2010-02-09

The genetic cause of hypertrophic cardiomyopathy remains unexplained in a substantial proportion cases. Formin homology 2 domain containing 3 (FHOD3) may have role the pathogenesis cardiac hypertrophy but has not been implicated cardiomyopathy. This study sought to investigate relation between FHOD3 mutations and development was sequenced by massive parallel sequencing 3,189 unrelated probands 2,777 patients with no evidence (disease control subjects). authors evaluated protein-altering...

10.1016/j.jacc.2018.10.001 article EN cc-by-nc-nd Journal of the American College of Cardiology 2018-11-01

Abstract Background Cardiac sequelae of past SARS-CoV-2 infection are still poorly documented. We conducted a cross-sectional study in health-care workers to report evidence pericarditis and myocarditis after infection. Methods studied 139 with confirmed (103 diagnosed by RT-PCR 36 serology). Participants underwent clinical assessment, electrocardiography, laboratory tests including immune cell profiling cardiac magnetic resonance (CMR). Pericarditis was when classical criteria were present,...

10.1101/2020.07.12.20151316 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-07-14

Disease penetrance in genotype-positive (G+) relatives of families with dilated cardiomyopathy (DCM) and the characteristics associated DCM onset these individuals are unknown. This study sought to determine new diagnosis G+ identify factors development. The authors evaluated 779 patients (age 35.8 ± 17.3 years; 459 [59%] females; 367 [47%] variants TTN) without followed at 25 Spanish centers. After a median follow-up 37.1 months (Q1-Q3: 16.3-63.8 months), 85 (10.9%) developed (incidence...

10.1016/j.jacc.2024.02.036 article EN cc-by-nc-nd Journal of the American College of Cardiology 2024-04-01
Luís R. Lopes Maria Angela Losi Nabeel Sheikh Cécile Laroche Philippe Charron and 95 more Juan R. Gimeno Juan Pablo Kaski Aldo P. Maggioni Luigi Tavazzi Eloisa Arbustini Dulce Brito Jelena Čelutkienė Albert Hagège Aleš Linhart Jens Mogensen José Manuel García‐Pinilla Tomás Ripoll‐Vera Hubert Seggewiß Eduardo Villacorta Alida L.P. Caforio Perry Elliott Chris P Gale Branko Beleslin Andrzej Budaj Ovidiu Chioncel Nikolaos Dagres Nicolas Danchin David Erlinge Jonathan Emberson Michael Glikson Alastair Gray Meral Kayıkçıoğlu Aldo P. Maggioni Klaudia Vivien Nagy Aleksandr Nedoshivin Anna-Sonia Petronio Jolien Roo Hesselink Lars Wallentin Uwe Zeymer Alida L.P. Caforio Juan R. Gimeno Philippe Charron Perry Elliott Juan Pablo Kaski Aldo P. Maggioni Luigi Tavazzi Michał Tendera С. М. Комиссарова Н. Н. Чакова S. S. Niyazova Aleš Linhart Petr Kuchynka T Palecek Jana Podzimková Marek Fikrle Eneida R. Nemecek Henning Bundgaard Jacob Tfelt‐Hansen Juliane Theilade Jens Jakob Thune Å.B. Axelsson Jens Mogensen F.L. Henriksen Thomas Morris Hey Søren K. Nielsen Lars Videbæk Simon Andreasen H Arnsted Anas M. Saad Muzaffar Ali Jyri Lommi Tiina Heliö M S Nieminen Olivier Dubourg Nicolas Mansencal Murat Nihat Arslan V. Siam Tsieu Thibaud Damy Aziz Guellich Soulef Guendouz Claire Marie Tissot Aurélia Lamine Stéphane Rappeneau Albert Hagège Michel Desnos A Bachet M. Hamzaoui Philippe Charron R Isnard L. Legrand Carole Maupain Estelle Gandjbakhch Mathieu Kerneïs J.F. Pruny Anna Bauer Barbara Pfeiffer S B Felix Marcus Dörr Sabine Kaczmarek Kristin Lehnert

The interaction between common cardiovascular risk factors (CVRF) and hypertrophic cardiomyopathy (HCM) is poorly studied. We sought to explore the relation CVRF clinical characteristics of patients with HCM enrolled in EURObservational Research Programme (EORP) Cardiomyopathy registry.1739 were hypertension (HT), diabetes (DM), body mass index (BMI), traits was analysed. Analyses stratified according presence or absence a pathogenic variant sarcomere gene. prevalence HT, DM, obesity (Ob)...

10.1093/ehjqcco/qcac006 article EN cc-by European Heart Journal - Quality of Care and Clinical Outcomes 2022-02-04

Abstract Aims Late gadolinium enhancement (LGE) is frequently found in patients with dilated cardiomyopathy (DCM); there little information about its frequency and distribution pattern according to the underlying genetic substrate. We sought describe LGE patterns genotypes analyse risk of major ventricular arrhythmias (MVA) patterns. Methods results Cardiac magnetic resonance findings genetics were performed a cohort 600 DCM followed at 20 Spanish centres. After exclusion individuals...

10.1093/ehjci/jead184 article EN cc-by-nc European Heart Journal - Cardiovascular Imaging 2023-08-10

Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by deficiency in the enzyme α-galactosidase A. This defect leads to progressive accumulation of glycosphingolipids, resulting kidney, heart, and nervous system damage, which contributes significant morbidity mortality. Early diagnosis essential prevent irreversible damage optimize treatment strategies. Recent research aims provide better understanding FD pathophysiology improve management approaches. study an...

10.1016/j.nbd.2025.106908 article EN cc-by-nc-nd Neurobiology of Disease 2025-04-14
Coming Soon ...